Galapagos NV(GLPG),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

GLPG Galapagos NV

Market Closed 12-12 16:00:00 EST

31.69

-0.88

-2.70%

盘后31.69

+0.000.00%

17:56 EST

High32.50	Low31.66	Vol62.71K
Open32.25	D1 Closing32.57	Amplitude2.56%
Mkt Cap2.09B	Tradable Cap2.06B	Total Shares65.90M
T/O2.00M	T/O Rate0.10%	Tradable Shares65.05M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"GLPG","market":"US","secType":"STK","nameCN":"Galapagos NV","latestPrice":31.69,"timestamp":1765573200000,"preClose":32.57,"halted":0,"volume":62711,"hourTrading":{"tag":"盘后","latestPrice":31.69,"preClose":31.69,"latestTime":"17:56 EST","volume":3010,"amount":95386.9,"timestamp":1765580176075},"delay":0,"floatShares":65046221,"shares":65897071,"eps":-7.764387,"marketStatus":"Market Closed","change":-0.88,"latestTime":"12-12 16:00:00 EST","open":32.25,"high":32.495,"low":31.66,"amount":2001136.1045279999,"amplitude":0.025637,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-7.764387,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":1,"adrRate":1,"listingDate":1431576000000,"exchange":"NASDAQ","adjPreClose":32.57,"preHourTrading":{"tag":"盘前","latestPrice":32.21,"preClose":32.57,"latestTime":"09:29 EST","volume":816,"amount":26240.41392,"timestamp":1765549770047},"postHourTrading":{"tag":"盘后","latestPrice":31.69,"preClose":31.69,"latestTime":"17:56 EST","volume":3010,"amount":95386.9,"timestamp":1765580176075},"volumeRatio":0.7390633094503878,"impliedVol":0.0544,"impliedVolPercentile":0.048},"requestUrl":"/m/hq/s/GLPG","defaultTab":"news","newsList":[{"id":"2586945259","title":"Galapagos NV Receives Transparency Notifications from Bank of America","url":"https://stock-news.laohu8.com/highlight/detail?id=2586945259","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586945259?lang=en_us&edition=fundamental","pubTime":"2025-11-26 19:31","pubTimestamp":1764156686,"startTime":"0","endTime":"0","summary":"Galapagos ( ($GLPG) ) has shared an update. On November 26, 2025, Galapagos NV announced that it received transparency notifications from Bank of A...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/galapagos-nv-receives-transparency-notifications-from-bank-of-america?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/galapagos-nv-receives-transparency-notifications-from-bank-of-america?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0130103400.USD","BK4585","LU0320765646.SGD","LU0256863811.USD","LU1069347547.HKD","LU1162221912.USD","BK4559","LU2129689605.HKD","LU1267930227.SGD","BAC","IE00BBT3K403.USD","IE0001KFT4U8.USD","LU1035773651.USD","IE00B19Z3581.USD","LU0149725797.USD","BK4588","IE00B7SZLL34.SGD","LU0106831901.USD","LU0053666078.USD","LU0321505439.SGD","LU1804176565.USD","LU0098860793.USD","LU2265009873.SGD","GLPG","IE00BLSP4452.SGD","LU0971096721.USD","LU2129689431.USD","LU1074936037.SGD","LU0417517546.SGD","BK4553","IE0002270589.USD","LU0320765489.SGD","LU0640476718.USD","LU0314106906.USD","LU1201861165.SGD","LU1718418525.SGD","LU2129689514.USD","LU1496350171.SGD","BK4581","LU0203345920.USD","LU0128525689.USD","LU0052756011.USD","LU0203347892.USD","LU1280957306.USD","LU1363072403.SGD","LU1496350502.SGD","IE0034235188.USD","IE00BZ1G4Q59.USD","LU1894683264.USD","IE00B1BXHZ80.USD"],"gpt_icon":0},{"id":"2581887799","title":"RBC Adjusts Price Target on Galapagos to $32 From $28, Maintains Sector Perform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2581887799","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581887799?lang=en_us&edition=fundamental","pubTime":"2025-11-08 00:21","pubTimestamp":1762532497,"startTime":"0","endTime":"0","summary":"Galapagos (GLPG) has an average rating of hold and mean price target of $33.89, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks an","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","GLPG"],"gpt_icon":0},{"id":"2580291140","title":"Galapagos NV  expected to post a loss of 41 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2580291140","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580291140?lang=en_us&edition=fundamental","pubTime":"2025-11-03 19:12","pubTimestamp":1762168325,"startTime":"0","endTime":"0","summary":"Galapagos NV  expected to post a loss of41cents a share - Earnings Preview Galapagos NV GLPG.OQ, GLPG.O is expected to  show a rise in quarterly revenue when it reports  results on November 5 for the ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251103:nL8N3WF0PC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GLPG","BK4139"],"gpt_icon":0},{"id":"2579108507","title":"Galapagos NV Strengthens Board with Strategic Appointments","url":"https://stock-news.laohu8.com/highlight/detail?id=2579108507","media":"TIPRANKS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579108507?lang=en_us&edition=fundamental","pubTime":"2025-10-31 04:59","pubTimestamp":1761857950,"startTime":"0","endTime":"0","summary":"Galapagos ( ($GLPG) ) has provided an announcement. On October 30, 2025, Galapagos NV announced significant changes to its Board of Directors to st...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/galapagos-nv-strengthens-board-with-strategic-appointments?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/galapagos-nv-strengthens-board-with-strategic-appointments?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","GLPG"],"gpt_icon":0},{"id":"2577365475","title":"RBC Raises Price Target on Galapagos to $28 From $27, Keeps Sector Perform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2577365475","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577365475?lang=en_us&edition=fundamental","pubTime":"2025-10-22 19:15","pubTimestamp":1761131748,"startTime":"0","endTime":"0","summary":"Galapagos (GLPG) has an average rating of hold and mean price target of $32.88, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks an","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","GLPG"],"gpt_icon":0},{"id":"2577365978","title":"Galapagos Nv : Leerink Partners Raises to Outperform From Market Perform; Raises Target Price to $40 From $29","url":"https://stock-news.laohu8.com/highlight/detail?id=2577365978","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577365978?lang=en_us&edition=fundamental","pubTime":"2025-10-22 19:11","pubTimestamp":1761131504,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251022:nFWN3W324F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GLPG","BK4139"],"gpt_icon":0},{"id":"2577368759","title":"Galapagos (GLPG) Gets a Hold from RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2577368759","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577368759?lang=en_us&edition=fundamental","pubTime":"2025-10-22 18:37","pubTimestamp":1761129447,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Brian Abrahams maintained a Hold rating on Galapagos yesterday and set a price target of $28.00. The company’s shares closed ye...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/galapagos-glpg-gets-a-hold-from-rbc-capital-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/galapagos-glpg-gets-a-hold-from-rbc-capital-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029864427.USD","LU0708994859.HKD","BK4139","LU1267930573.SGD","LU0310800379.SGD","GLPG","BK4207","LU0128525929.USD"],"gpt_icon":0},{"id":"2577076278","title":"Galapagos Raised to Outperform From Market Perform by Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2577076278","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577076278?lang=en_us&edition=fundamental","pubTime":"2025-10-22 04:53","pubTimestamp":1761079980,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/GLPG/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 21, 2025 16:53 ET (20:53 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GLPG"],"gpt_icon":0},{"id":"2577802398","title":"Leerink upgrades Galapagos on confidence after cell therapy exit","url":"https://stock-news.laohu8.com/highlight/detail?id=2577802398","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577802398?lang=en_us&edition=fundamental","pubTime":"2025-10-22 04:15","pubTimestamp":1761077738,"startTime":"0","endTime":"0","summary":"Leerink analyst Faisal Khurshid upgraded Galapagos (GLPG) to Outperform from Market Perform with a price target of $40, up from $29. The firm has “...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/leerink-upgrades-galapagos-on-confidence-after-cell-therapy-exit-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/leerink-upgrades-galapagos-on-confidence-after-cell-therapy-exit-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GLPG","BK4139"],"gpt_icon":0},{"id":"2577282711","title":"Top Premarket Decliners","url":"https://stock-news.laohu8.com/highlight/detail?id=2577282711","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577282711?lang=en_us&edition=fundamental","pubTime":"2025-10-21 20:00","pubTimestamp":1761048044,"startTime":"0","endTime":"0","summary":"Neuphoria Therapeutics  stock was down 67% in recent Tuesday premarket activity after the company said overnight that a phase 3 trial of BNC210 for the acute treatment of social anxiety disorder did not meet its primary endpoint.Galapagos  shares were down 13% after the company said it decided to wind down its cell therapy operations.Newmont  stock was 4% lower, erasing Monday's gain.PulteGroup  shares were down 2.1% after the company posted lower Q3 earnings and revenue.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4088","BK4533","LU0345780281.USD","LU0612318971.USD","LU1280957306.USD","LU1430597077.USD","LU2462611646.USD","BK7104","NEUP","PHM","BK4585","LU2498475776.HKD","LU0345780521.USD","LU0724618789.USD","GLPG","LU0055631609.USD","LU0300736492.USD","LU0868494617.USD","LU0654597011.USD","BK4139","LU0266512473.USD","LU0868494708.USD","LU1023059493.AUD","LU0330918003.SGD","LU1883866441.USD","LU0345780950.USD","LU0788108826.HKD","LU0456854461.SGD","NEM.AU","NEM","LU0498741114.HKD","BK4017","LU0278409577.USD","LU0788109121.HKD","LU1223082519.USD","BK4532","LU0612318385.USD","LU0345781412.USD","LU0640476718.USD","BK4588","LU1223082196.USD","LU0300736062.USD","LU0368265764.SGD","LU0266512127.USD","LU0498741890.SGD","LU0075056555.USD","BK4570","LU1223083913.SGD","LU1699723380.USD","LU0630314457.HKD"],"gpt_icon":0},{"id":"2577299328","title":"Galapagos Shares Sink on Plans to Wind Down Cell-Therapy Business","url":"https://stock-news.laohu8.com/highlight/detail?id=2577299328","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577299328?lang=en_us&edition=fundamental","pubTime":"2025-10-21 18:41","pubTimestamp":1761043260,"startTime":"0","endTime":"0","summary":"Shares in Galapagos NV dropped sharply after the Belgian biotech firm said it would wind down its cell-therapy operations, putting paid to plans to sell the business off after no viable offers were made.\"The intention to wind down follows a comprehensive review of strategic alternatives, including a potential divestiture,\" Galapagos said Tuesday.It said some 365 jobs would be lost across the business's operations in Europe, the U.S. and China. The decision, once confirmed by labor-council procedures, will imply additional operating costs of 100 million to 125 million euros  from this quarter through 2026, and one-off restructuring costs of 150 million to 200 million euros next year.Amsterdam shares traded 16% lower at 25 euros Tuesday morning. Shares have lost 5.7% year-to-date.The decision to shutter the cell-therapy business comes after Galapagos said earlier this month that it was looking at a potential sale of the business. But that idea proved a nonstarter, Galapagos said.\"Followi","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GLPG"],"gpt_icon":0},{"id":"2577254548","title":"Galapagos intends to wind down cell therapy business","url":"https://stock-news.laohu8.com/highlight/detail?id=2577254548","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2577254548?lang=en_us&edition=fundamental","pubTime":"2025-10-21 17:55","pubTimestamp":1761040512,"startTime":"0","endTime":"0","summary":"Galapagos (GLPG) announced its intention to wind down its cell therapy business and pursue new business development transactions with its available...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/galapagos-intends-to-wind-down-cell-therapy-business-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/galapagos-intends-to-wind-down-cell-therapy-business-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","GLPG"],"gpt_icon":0},{"id":"2575152407","title":"Analysts Offer Insights on Healthcare Companies: Galapagos (GLPG), Pharvaris (PHVS) and Stevanato Group (STVN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2575152407","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575152407?lang=en_us&edition=fundamental","pubTime":"2025-10-13 22:03","pubTimestamp":1760364212,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Galapagos (GLPG – Research Report), Pharvaris (PHV...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-galapagos-glpg-pharvaris-phvs-and-stevanato-group-stvn-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-galapagos-glpg-pharvaris-phvs-and-stevanato-group-stvn-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4007","BK4581","GLPG","BK4121","HCSG","XLV","LABU","BK4137","PHVS","BK4139","BK4585","STVN","BK4588","XBI"],"gpt_icon":0},{"id":"2573159670","title":"Analysts Offer Insights on Healthcare Companies: BioNTech SE (BNTX), Stevanato Group (STVN) and Galapagos (GLPG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2573159670","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2573159670?lang=en_us&edition=fundamental","pubTime":"2025-10-06 21:20","pubTimestamp":1759756810,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on BioNTech SE (BNTX – Research Report), Stevanato Group (STVN – Res...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-biontech-se-bntx-stevanato-group-stvn-and-galapagos-glpg-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-biontech-se-bntx-stevanato-group-stvn-and-galapagos-glpg-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2177674079.SGD","SGXZ58947870.SGD","LU0441851309.USD","LU1048588211.SGD","SG9999014484.SGD","LU0264606111.USD","IE0034224299.USD","SG9999013486.USD","BK4551","GLPG","HCSG","LU0261945553.USD","SG9999002414.USD","LU0210637038.USD","LABU","LU1242518931.SGD","LU0345775950.USD","LU0572939691.SGD","SG9999001135.SGD","LU2008162690.USD","SG9999002406.SGD","LU2065171311.SGD","SG9999013460.SGD","STVN","BK4503","BK4548","LU0516422366.SGD","BK4220","XLV","LU2065170008.USD","BK4585","BK4588","LU2065169927.USD","SG9999005177.SGD","LU0072462343.USD","LU0572940350.SGD","BK4539","BNTX","LU0348788117.USD","LU0516423174.USD","LU1861220207.SGD","LU0589944569.HKD","SG9999013478.USD","BK4581","XBI","LU0823039010.USD","BK4568","BK4121","SG9999002604.SGD"],"gpt_icon":0},{"id":"2572557466","title":"Galapagos Exploring Divesting From Cell Therapy Business","url":"https://stock-news.laohu8.com/highlight/detail?id=2572557466","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572557466?lang=en_us&edition=fundamental","pubTime":"2025-10-02 04:27","pubTimestamp":1759350420,"startTime":"0","endTime":"0","summary":"Galapagos is exploring strategic alternatives for its cell therapy business, including a potential divestiture.The Belgian biotechnology company said Wednesday it has received a limited number of non-binding offers, mostly from financial investors, to acquire the cell therapy business. Parties interested in acquiring the business have had access to a comprehensive data room and confidential presentations on the cell therapy business.Galapagos' board and management are now working with the potential bidders to finalize due diligence and see if they can raise the necessary funding. The deadline for potential bidders to put forward fully financed binding offers will happen in the coming weeks, Galapagos said.The board expects to make a decision about which strategic alternative it will choose after it receives those binding offers, if there are any. Galapagos will announce its decision no later than Nov. 5, when it plans to release its third-quarter results, it said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GLPG"],"gpt_icon":0},{"id":"2572579175","title":"Galapagos provides update on strategic alternatives for cell therapy business","url":"https://stock-news.laohu8.com/highlight/detail?id=2572579175","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572579175?lang=en_us&edition=fundamental","pubTime":"2025-10-02 04:05","pubTimestamp":1759349130,"startTime":"0","endTime":"0","summary":"Galapagos (GLPG) announced that its board of directors had decided to explore all strategic alternatives for its cell therapy business, including a...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/galapagos-provides-update-on-strategic-alternatives-for-cell-therapy-business-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/galapagos-provides-update-on-strategic-alternatives-for-cell-therapy-business-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GLPG","BK4139"],"gpt_icon":0},{"id":"2567311408","title":"Morgan Stanley Sticks to Its Sell Rating for Galapagos (GLPG)","url":"https://stock-news.laohu8.com/highlight/detail?id=2567311408","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2567311408?lang=en_us&edition=fundamental","pubTime":"2025-09-15 20:55","pubTimestamp":1757940938,"startTime":"0","endTime":"0","summary":"Morgan Stanley analyst Judah Frommer maintained a Sell rating on Galapagos today and set a price target of $22.00. The company’s shares closed last...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/morgan-stanley-sticks-to-its-sell-rating-for-galapagos-glpg-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/morgan-stanley-sticks-to-its-sell-rating-for-galapagos-glpg-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GLPG"],"gpt_icon":0},{"id":"2553204525","title":"Galapagos Nv : Leerink Partners Raises Target Price to $29 From $24","url":"https://stock-news.laohu8.com/highlight/detail?id=2553204525","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2553204525?lang=en_us&edition=fundamental","pubTime":"2025-07-24 19:00","pubTimestamp":1753354859,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250724:nFWN3TL1R3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["GLPG","BK4139"],"gpt_icon":0},{"id":"1142984251","title":"Stock Track | Galapagos NV Plummets 13.49% Pre-market on Massive Q2 Earnings Miss and Swing to Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=1142984251","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142984251?lang=en_us&edition=fundamental","pubTime":"2025-07-24 16:07","pubTimestamp":1753344430,"startTime":"0","endTime":"0","summary":"Shares of Galapagos NV (GLPG) are set to open sharply lower in pre-market trading on Thursday, plunging 13.49% following the release of the company's disappointing second-quarter and first-half 2025...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["GLPG"],"gpt_icon":0},{"id":"1104428000","title":"Stock Track | Galapagos NV Plunges 8% After Q2 Earnings Miss and Widened Losses","url":"https://stock-news.laohu8.com/highlight/detail?id=1104428000","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1104428000?lang=en_us&edition=fundamental","pubTime":"2025-07-24 15:02","pubTimestamp":1753340553,"startTime":"0","endTime":"0","summary":"Shares of Galapagos NV (GLPG) tumbled 8.02% in Thursday's trading session following the release of its disappointing second-quarter 2025 financial results. The biotechnology company reported a...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["GLPG"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.glpg.com","stockEarnings":[{"period":"1week","weight":0.0032},{"period":"1month","weight":-0.0192},{"period":"3month","weight":-0.0103},{"period":"6month","weight":0.1019},{"period":"1year","weight":0.1746},{"period":"ytd","weight":0.1524}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667 that has completed phase 1b trial; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in Phase1/2 trial in relapsed/refractory non-hodgkin lymphoma; GLPG5201, a CD19 CAR-T product candidates manufactured at point-of-care, currently in phase 1/2 trial in replapsed/refractory chronic lymphocytic leukemia; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc.; and AbbVie S.à r.l. Galapagos NV was incorporated in 1999 and is headquartered in Mechelen, Belgium.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.028345},{"month":2,"riseRate":0.2,"avgChangeRate":-0.060645},{"month":3,"riseRate":0.4,"avgChangeRate":0.011255},{"month":4,"riseRate":0.6,"avgChangeRate":-0.000231},{"month":5,"riseRate":0.4,"avgChangeRate":0.031125},{"month":6,"riseRate":0.181818,"avgChangeRate":-0.039259},{"month":7,"riseRate":0.636364,"avgChangeRate":0.068834},{"month":8,"riseRate":0.181818,"avgChangeRate":-0.030314},{"month":9,"riseRate":0.454545,"avgChangeRate":-0.018717},{"month":10,"riseRate":0.363636,"avgChangeRate":-0.009712},{"month":11,"riseRate":0.454545,"avgChangeRate":-0.004236},{"month":12,"riseRate":0.727273,"avgChangeRate":0.048331}],"exchange":"NASDAQ","name":"Galapagos NV","nameEN":"Galapagos NV"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Galapagos NV(GLPG),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Galapagos NV(GLPG) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Galapagos NV,GLPG,Galapagos NV股票,Galapagos NV股票老虎,Galapagos NV股票老虎国际,Galapagos NV行情,Galapagos NV股票行情,Galapagos NV股价,Galapagos NV股市,Galapagos NV股票价格,Galapagos NV股票交易,Galapagos NV股票购买,Galapagos NV股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Galapagos NV(GLPG),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Galapagos NV(GLPG) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}